Terms: = Germ cell tumor AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Clinical Outcome
4 results:
1. Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.
Khan FH; Pandian V; Ramraj S; Natarajan M; Aravindan S; Herman TS; Aravindan N
BMC Cancer; 2015 Jul; 15():514. PubMed ID: 26159519
[TBL] [Abstract] [Full Text] [Related]
2. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
[TBL] [Abstract] [Full Text] [Related]
3. Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients.
Simons DL; Lee G; Kirkwood JM; Lee PP
J Transl Med; 2011 May; 9():52. PubMed ID: 21545749
[TBL] [Abstract] [Full Text] [Related]
4. p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.
Panicker SP; Raychaudhuri B; Sharma P; Tipps R; Mazumdar T; Mal AK; Palomo JM; Vogelbaum MA; Haque SJ
Oncotarget; 2010 Aug; 1(4):289-303. PubMed ID: 21304179
[TBL] [Abstract] [Full Text] [Related]
